Skip to main content

Precision science

inspired by human biology.

Vividion Therapeutics is removing the boundaries of druggability to develop therapies for patients with critical unmet needs across multiple therapeutic areas.
A unified team with a singular mission. We are committed to delivering solutions for patients who may have once thought there was no treatment option for their disease.
We are reimagining the “impossible” to deliver possibility for all by combining decades of research with unprecedented know-how. We envision a future where there are treatments for all patients, no matter how difficult their disease is to target. 
Publications
09/22/2021
article
Vividion Therapeutics Announces Formation of Scientific Advisory Board
Read more
08/23/2021
article
Bayer AG Completes its Acquisition of Vividion Therapeutics
Read more
We’re hiring! Come work with a passionate team, pushing the boundaries of what small molecules are capable of.